PFBT
TAK icon

Parkside Financial Bank & Trust’s Takeda Pharmaceutical TAK Stock Holding History

Parkside Financial Bank & Trust’s Portfolio TAK Stock Details TAK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$43.3K Buy
2,702
+142
+6% +$2.35K ﹤0.01% 1092
2026
Q1 		$47.4K Hold
2,560
– – ﹤0.01% 975
2025
Q4 		$39.9K Buy
2,560
+1,684
+192% +$24.1K ﹤0.01% 1049
2025
Q3 		$12.8K Sell
876
-471
-35% -$7K ﹤0.01% 1424
2025
Q2 		$20.8K Buy
1,347
+809
+150% +$12K ﹤0.01% 1219
2025
Q1 		$8K Buy
538
+270
+101% +$3.78K ﹤0.01% 1486
2024
Q4 		$3.55K Hold
268
– – ﹤0.01% 1519
2024
Q3 		$3.81K Buy
268
+266
+13,300% +$3.77K ﹤0.01% 1484
2024
Q2 		$26 Sell
2
-58
-97% -$768 ﹤0.01% 2035
2024
Q1 		$834 Sell
60
-148
-71% -$2.15K ﹤0.01% 1653
2023
Q4 		$2.97K Buy
+208
New +$2.95K ﹤0.01% 1427

Other funds holding TAK

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return

Parkside Financial Bank & Trust's TAK Position: Q2 2026 in Review

Parkside Financial Bank & Trust increased its Takeda Pharmaceutical (TAK) stake by 5.5% in Q2 2026, buying an estimated $2.35K and bringing the position to 2,702 shares worth $43.3K. The position accounts for ﹤0.01% of the portfolio, ranked #1092.

Parkside Financial Bank & Trust first reported a position in TAK in Q4 2023 and has held it in 11 quarters since. The position peaked at $47.4K in Q1 2026. 379 funds tracked by Wall St. Rank hold TAK as of Q2 2026.

  • Parkside Financial Bank & Trust held 2,702 shares of Takeda Pharmaceutical worth $43.3K as of Q2 2026.
  • Parkside Financial Bank & Trust bought 142 Takeda Pharmaceutical shares in Q2 2026, an estimated $2.35K.
  • Takeda Pharmaceutical made up ﹤0.01% of Parkside Financial Bank & Trust's portfolio in Q2 2026, its #1092 holding.
  • Parkside Financial Bank & Trust first reported a position in Takeda Pharmaceutical in Q4 2023 and has held it in 11 quarters since.
  • Parkside Financial Bank & Trust's Takeda Pharmaceutical position peaked at $47.4K in Q1 2026.
  • 379 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q2 2026.

Based on Parkside Financial Bank & Trust's 13F filing for Q2 2026, filed 4 Sep 2026.